163 related articles for article (PubMed ID: 21036696)
1. Inhibition of Notch signaling reduces the stem-like population of breast cancer cells and prevents mammosphere formation.
Grudzien P; Lo S; Albain KS; Robinson P; Rajan P; Strack PR; Golde TE; Miele L; Foreman KE
Anticancer Res; 2010 Oct; 30(10):3853-67. PubMed ID: 21036696
[TBL] [Abstract][Full Text] [Related]
2. Targeting notch signaling pathway in breast cancer stem cells through drug repurposing approach.
Pathak Y; Camps I; Mishra A; Tripathi V
Mol Divers; 2023 Dec; 27(6):2431-2440. PubMed ID: 36376717
[TBL] [Abstract][Full Text] [Related]
3. Signaling pathways governing the maintenance of breast cancer stem cells and their therapeutic implications.
Ordaz-Ramos A; Tellez-Jimenez O; Vazquez-Santillan K
Front Cell Dev Biol; 2023; 11():1221175. PubMed ID: 37492224
[TBL] [Abstract][Full Text] [Related]
4. Deciphering Common Traits of Breast and Ovarian Cancer Stem Cells and Possible Therapeutic Approaches.
Lučić I; Kurtović M; Mlinarić M; Piteša N; Čipak Gašparović A; Sabol M; Milković L
Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445860
[TBL] [Abstract][Full Text] [Related]
5. Resistance to Trastuzumab.
Vivekanandhan S; Knutson KL
Cancers (Basel); 2022 Oct; 14(20):. PubMed ID: 36291900
[TBL] [Abstract][Full Text] [Related]
6. Breast cancer: molecular mechanisms of underlying resistance and therapeutic approaches.
Tufail M; Cui J; Wu C
Am J Cancer Res; 2022; 12(7):2920-2949. PubMed ID: 35968356
[TBL] [Abstract][Full Text] [Related]
7. Notch signaling in female cancers: a multifaceted node to overcome drug resistance.
Giuli MV; Mancusi A; Giuliani E; Screpanti I; Checquolo S
Cancer Drug Resist; 2021; 4(4):805-836. PubMed ID: 35582386
[TBL] [Abstract][Full Text] [Related]
8. Modulation of Notch Signaling Pathway by Bioactive Dietary Agents.
Kiesel VA; Stan SD
Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35408894
[TBL] [Abstract][Full Text] [Related]
9. A Phase Ib Dose Escalation Trial of RO4929097 (a γ-secretase inhibitor) in Combination with Exemestane in Patients with ER + Metastatic Breast Cancer (MBC).
Means-Powell JA; Mayer IA; Ismail-Khan R; Del Valle L; Tonetti D; Abramson VG; Sanders MS; Lush RM; Sorrentino C; Majumder S; Miele L
Clin Breast Cancer; 2022 Feb; 22(2):103-114. PubMed ID: 34903452
[TBL] [Abstract][Full Text] [Related]
10. Cancer and stem cells.
Yin W; Wang J; Jiang L; James Kang Y
Exp Biol Med (Maywood); 2021 Aug; 246(16):1791-1801. PubMed ID: 33820469
[TBL] [Abstract][Full Text] [Related]
11. Notch Signaling in Vascular Endothelial Cells, Angiogenesis, and Tumor Progression: An Update and Prospective.
Akil A; Gutiérrez-García AK; Guenter R; Rose JB; Beck AW; Chen H; Ren B
Front Cell Dev Biol; 2021; 9():642352. PubMed ID: 33681228
[TBL] [Abstract][Full Text] [Related]
12. Unlocking the Secrets of Cancer Stem Cells with γ-Secretase Inhibitors: A Novel Anticancer Strategy.
Ghanbari-Movahed M; Ghanbari-Movahed Z; Momtaz S; Kilpatrick KL; Farzaei MH; Bishayee A
Molecules; 2021 Feb; 26(4):. PubMed ID: 33673088
[TBL] [Abstract][Full Text] [Related]
13. Nanosized Drug Delivery Systems for Breast Cancer Stem Cell Targeting.
Lv L; Shi Y; Wu J; Li G
Int J Nanomedicine; 2021; 16():1487-1508. PubMed ID: 33654398
[TBL] [Abstract][Full Text] [Related]
14. Targeting Notch and EGFR signaling in human mucoepidermoid carcinoma.
Ni W; Chen Z; Zhou X; Yang R; Yu M; Lu J; Kaye FJ; Wu L
Signal Transduct Target Ther; 2021 Jan; 6(1):27. PubMed ID: 33473104
[TBL] [Abstract][Full Text] [Related]
15. Breast cancer stem cells: A review of their characteristics and the agents that affect them.
Shan NL; Shin Y; Yang G; Furmanski P; Suh N
Mol Carcinog; 2021 Feb; 60(2):73-100. PubMed ID: 33428807
[TBL] [Abstract][Full Text] [Related]
16. Notch Signaling in Breast Cancer: A Role in Drug Resistance.
BeLow M; Osipo C
Cells; 2020 Sep; 9(10):. PubMed ID: 33003540
[TBL] [Abstract][Full Text] [Related]
17. Recent Advances in Targeting of Breast Cancer Stem Cells Based on Biological Concepts and Drug Delivery System Modification.
Aaliyari-Serej Z; Ebrahimi A; Barazvan B; Ebrahimi-Kalan A; Hajiasgharzadeh K; Kazemi T; Baradaran B
Adv Pharm Bull; 2020 Jul; 10(3):338-349. PubMed ID: 32665892
[TBL] [Abstract][Full Text] [Related]
18. A phase I study of an oral selective gamma secretase (GS) inhibitor RO4929097 in combination with neoadjuvant paclitaxel and carboplatin in triple negative breast cancer.
Sardesai S; Badawi M; Mrozek E; Morgan E; Phelps M; Stephens J; Wei L; Kassem M; Ling Y; Lustberg M; Stover D; Williams N; Layman R; Reinbolt R; VanDeusen J; Cherian M; Grever M; Carson W; Ramaswamy B; Wesolowski R
Invest New Drugs; 2020 Oct; 38(5):1400-1410. PubMed ID: 31953695
[TBL] [Abstract][Full Text] [Related]
19. miR-200c suppresses stemness and increases cellular sensitivity to trastuzumab in HER2+ breast cancer.
Tang H; Song C; Ye F; Gao G; Ou X; Zhang L; Xie X; Xie X
J Cell Mol Med; 2019 Dec; 23(12):8114-8127. PubMed ID: 31599500
[TBL] [Abstract][Full Text] [Related]
20. Expression of Oncogenic Drivers in 3D Cell Culture Depends on Nuclear ATP Synthesis by NUDT5.
Pickup KE; Pardow F; Carbonell-Caballero J; Lioutas A; Villanueva-Cañas JL; Wright RHG; Beato M
Cancers (Basel); 2019 Sep; 11(9):. PubMed ID: 31510016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
